Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection (Q37862747)

24 August 2017

1 reference

title

Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection (English)

1 reference

24 August 2017

0 references

0 references

anti-retroviral agent

0 references

author

Sharon R. Lewin

6

1 reference

24 August 2017

Reena Rajasuriar

3

0 references

author name string

Gregor F Lichtfuss

1

1 reference

24 August 2017

Jennifer Hoy

2

1 reference

24 August 2017

Marit Kramski

4

1 reference

24 August 2017

Suzanne M Crowe

5

1 reference

24 August 2017

1 April 2011

1 reference

24 August 2017

Biomarkers in Medicine

1 reference

24 August 2017

5

1 reference

24 August 2017

2

1 reference

24 August 2017

171-186

1 reference

Acute human immunodeficiency virus type 1 infection

24 August 2017

1 reference

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

21 January 2018

1 reference

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

21 January 2018

1 reference

Correlates of lending needles/syringes among HIV-seropositive injection drug users

21 January 2018

1 reference

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies

21 January 2018

1 reference

HIV transmission and high rates of late diagnoses among adults aged 50 years and over

21 January 2018

1 reference

Antiretroviral therapy and management of HIV infection

21 January 2018

1 reference

Biomarkers of immune dysfunction in HIV.

21 January 2018

1 reference

Interleukin 2 and its receptors: recent advances and new immunological functions

21 January 2018

1 reference

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage

21 January 2018

1 reference

Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals

21 January 2018

1 reference

Expression of CD69 on T-cell subsets in HIV-1 disease.

21 January 2018

1 reference

Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens

21 January 2018

1 reference

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients

21 January 2018

1 reference

From research tool to routine test: CD38 monitoring in HIV patients.

21 January 2018

1 reference

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

21 January 2018

1 reference

Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression

21 January 2018

1 reference

Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy

21 January 2018

1 reference

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

21 January 2018

1 reference

Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function.

21 January 2018

1 reference

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy

21 January 2018

1 reference

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation

21 January 2018

1 reference

Significant link between sCD30 changes and HIV viremia in patients treated with HAART.

21 January 2018

1 reference

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma

21 January 2018

1 reference

Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers

21 January 2018

1 reference

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection

21 January 2018

1 reference

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

21 January 2018

1 reference

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

21 January 2018

1 reference

Plasma levels of soluble CD14 independently predict mortality in HIV infection

21 January 2018

1 reference

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

C-reactive protein and coronary heart disease: predictive test or therapeutic target?

21 January 2018

1 reference

C-reactive protein is a marker for human immunodeficiency virus disease progression.

21 January 2018

1 reference

Association of C-reactive protein and HIV infection with acute myocardial infarction

21 January 2018

1 reference

Role of C-reactive protein in HIV infection: a pilot study.

21 January 2018

1 reference

Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy

21 January 2018

1 reference

Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients

21 January 2018

1 reference

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans

21 January 2018

1 reference

Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection

21 January 2018

1 reference

The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy

21 January 2018

1 reference

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

21 January 2018

1 reference

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

21 January 2018

1 reference

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

21 January 2018

1 reference

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 January 2018

1 reference

Collagen deposition limits immune reconstitution in the gut

21 January 2018

1 reference

Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels

21 January 2018

1 reference

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection

21 January 2018

1 reference

Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis

21 January 2018

1 reference

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.

21 January 2018

1 reference

Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy

21 January 2018

1 reference

Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.

21 January 2018

1 reference

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy

21 January 2018

1 reference

HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers

21 January 2018

1 reference

Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa

21 January 2018

1 reference

Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population

21 January 2018

1 reference

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock

21 January 2018

1 reference

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

21 January 2018

1 reference

Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis

21 January 2018

1 reference

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

21 January 2018

1 reference

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy

21 January 2018

1 reference

Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms

21 January 2018

1 reference

Molecular mechanisms of endotoxin tolerance

21 January 2018

1 reference

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

21 January 2018

1 reference

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

21 January 2018

1 reference

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

21 January 2018

1 reference

Comparison of CD4(+) T-cell subset distribution in chronically infected HIV(+) patients with various CD4 nadir counts.

21 January 2018

1 reference

Early immune senescence in HIV disease

21 January 2018

1 reference

CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines

21 January 2018

1 reference

The CD28 signaling pathway regulates glucose metabolism

21 January 2018

1 reference

CD28 extinction in human T cells: altered functions and the program of T-cell senescence

21 January 2018

1 reference

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women

21 January 2018

1 reference

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

21 January 2018

1 reference

Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection

21 January 2018

1 reference

No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy

21 January 2018

1 reference

Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.

21 January 2018

1 reference

Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy

21 January 2018

1 reference

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery

21 January 2018

1 reference

Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease

21 January 2018

1 reference

Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

21 January 2018

1 reference

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

Relationship between CD107a expression and cytotoxic activity

21 January 2018

1 reference

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

21 January 2018

1 reference

Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody

21 January 2018

1 reference

Role of natural killer cells in HIV pathogenesis

21 January 2018

1 reference

Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes.

21 January 2018

1 reference

HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity

21 January 2018

1 reference

Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Nomenclature of monocytes and dendritic cells in blood.

21 January 2018

1 reference

CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection

21 January 2018

1 reference

CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection

21 January 2018

1 reference

Increased monocyte tissue factor expression in coronary disease

21 January 2018

1 reference

The macrophage: the intersection between HIV infection and atherosclerosis.

21 January 2018

1 reference

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

21 January 2018

1 reference

Cancer biomarkers in HIV patients

21 January 2018

1 reference

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

21 January 2018

1 reference

Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study

21 January 2018

1 reference

Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study.

21 January 2018

1 reference

Interleukin-2 therapy in patients with HIV infection

21 January 2018

1 reference

Immunological and Virological Failure after Antiretroviral Therapy Is Associated with Enhanced Peripheral and Thymic Pathogenicity

21 January 2018

1 reference

CD56 negative NK cells: origin, function, and role in chronic viral disease

21 January 2018

1 reference

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease

21 January 2018

1 reference

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

21 January 2018

1 reference

The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo

21 January 2018

1 reference

Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.

21 January 2018

1 reference

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.11.15

1 reference

24 August 2017

1 reference